Volume 10, Issue 3 (2022)
Health Educ Health Promot 2022, 10(3): 477-481 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Delshad M, Abdollahi M, Pourhaji F, Azhdari Zarmehri H, Heidarnia A, Pourhaji F. Development and Initial Validation of the Coronavirus Pandemic Anxiety Scale. Health Educ Health Promot 2022; 10 (3) :477-481
URL: http://hehp.modares.ac.ir/article-5-60007-en.html
URL: http://hehp.modares.ac.ir/article-5-60007-en.html
1- “Department of Public Health” and “Health Sciences Research Center”, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
2- Department of Health Education and Health Promotion, Mashhad University of Medical Sciences, Mashhad, Iran
3- “Neuroscience Research Center”, and “Department of Physiology”, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
4- Department of Health Education and Health Promotion, Tarbiat Modares University, Tehran, Iran
2- Department of Health Education and Health Promotion, Mashhad University of Medical Sciences, Mashhad, Iran
3- “Neuroscience Research Center”, and “Department of Physiology”, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
4- Department of Health Education and Health Promotion, Tarbiat Modares University, Tehran, Iran
Abstract: (1326 Views)
Aims: This paper aimed to report the development and validation of the Coronavirus Pandemic Anxiety Scale, for assessing COVID-19-related anxiety.
Instrument & Methods: This is a methodological and psychometric study, we developed a 7-Item Generalized anxiety disorder of COVID-19 scale to measure symptoms of anxiety related to the COVID-19 pandemic to help identify people who might need mental health services. In developing the generalized anxiety disorder of COVID-19 scale items, we considered a previous theory and research on anxiety symptoms and symptoms reported in Iran. The scale was validated in the Razavi Khorasan (N=500).
Findings: The CVR in this study for the total scale was 0.81 indicating a satisfactory result. Also, the CVI for the scale was0.78, and the scale had good content validity. Confirmatory factor analysis showed a good fit for the seven-factor model. generalized anxiety disorder of covid-19 scale showed good internal consistency.
Conclusion: The results support the viability of generalized anxiety disorder on the COVID-19 scale as a tool to identify individuals experiencing COVID-19-related anxiety.
Instrument & Methods: This is a methodological and psychometric study, we developed a 7-Item Generalized anxiety disorder of COVID-19 scale to measure symptoms of anxiety related to the COVID-19 pandemic to help identify people who might need mental health services. In developing the generalized anxiety disorder of COVID-19 scale items, we considered a previous theory and research on anxiety symptoms and symptoms reported in Iran. The scale was validated in the Razavi Khorasan (N=500).
Findings: The CVR in this study for the total scale was 0.81 indicating a satisfactory result. Also, the CVI for the scale was0.78, and the scale had good content validity. Confirmatory factor analysis showed a good fit for the seven-factor model. generalized anxiety disorder of covid-19 scale showed good internal consistency.
Conclusion: The results support the viability of generalized anxiety disorder on the COVID-19 scale as a tool to identify individuals experiencing COVID-19-related anxiety.
Keywords: COVID-19 [MeSH], Coronavirus [MeSH], Pandemic [MeSH], Anxiety [MeSH], Mental Health [MeSH]
Article Type: Descriptive & Survey |
Subject:
Health Education and Health Behavior
Received: 2022/03/4 | Accepted: 2022/05/9 | Published: 2022/07/5
Received: 2022/03/4 | Accepted: 2022/05/9 | Published: 2022/07/5
References
1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239-42. [Link] [DOI:10.1001/jama.2020.2648]
2. Gholian M, Moghzi M, Zakerian M, Khorasani EC. COVID-19 vaccination coverage in low-income areas: outcomes, barriers, and facilitators. Iran Red Cres Med J. 2021;23(12). [Link]
3. Mousavi SH, Delshad MH, Acuti Martellucci C, Bhandari D, Ozaki A, Pourhaji F, et al. Community behavioral and perceived responses in the covid-19 outbreak in afghanistan: a cross-sectional study. Disaster Med Public Health Preparedness. 2021:1-7. [Link] [DOI:10.1017/dmp.2021.135]
4. Raykov T, Marcoulides GA. A first course in structural equation modeling. London: Routledge; 2006. [Link]
5. Bernardo ABI, Mendoza NB, Simon PD, Cunanan ALP, Dizon JIWT, Tarroja MCH, et al. Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation. Curr Psychol. 2022;41:5703-11. [Link] [DOI:10.1007/s12144-020-01193-2]
6. Pfefferbaum B, North CS. Mental Health and the Covid-19 Pandemic. N Engl J Med. 2020;383:510-2. [Link] [DOI:10.1056/NEJMp2008017]
7. Taylor S. The psychology of pandemics: preparing for the next global outbreak of infectious disease. Cambridge: Cambridge Scholars Publishing; 2019. [Link]
8. Lee SA. Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety. Death Stud. 2020;44(7):393-401. [Link] [DOI:10.1080/07481187.2020.1748481]
9. Balaratnasingam S, Janca A. Mass hysteria revisited. Curr Opin Psychiatry. 2006;19(2):171-4. [Link] [DOI:10.1097/01.yco.0000214343.59872.7a]
10. Liu S, Yang L, Zhang C, Xiang YT, Liu Z, Hu S, et al. Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry. 2020;7(4):e17-8. [Link] [DOI:10.1016/S2215-0366(20)30077-8]
11. Zhang SX, Wang Y, Rauch A, Wei F. Unprecedented disruption of lives and work: Health, distress and life satisfaction of working adults in China one month into the COVID-19 outbreak. medRxiv. 2020;288:112958. [Link] [DOI:10.1016/j.psychres.2020.112958]
12. Delshad MH, Pourhaji F, Pourhaji F, Azhdari Zarmehri H. The relationship between self-efficacy, self-care behavior, and generalized anxiety disorder in COVID-19: a path analysis model. 2022;12(1):111-21. [Link] [DOI:10.14710/nmjn.v12i1.32938]
13. Huremović D. Psychiatry of pandemics. New York: Springer; 2019. p. 95-118. [Link] [DOI:10.1007/978-3-030-15346-5_9]
14. Wang C, Pan R, Wan X, Tan Y, Xu L, McIntyre RS, et al. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain Behav Immun. 2020;87:40-8. [Link] [DOI:10.1016/j.bbi.2020.04.028]
15. Santabárbara J, Lasheras I, Lipnicki DM, Bueno-Notivol J, Pérez-Moreno M, López-Antón R, et al. Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies. Prog Neuro-Psychopharmacol Biol Psychiatry. 2021;109:110207. [Link] [DOI:10.1016/j.pnpbp.2020.110207]
16. Mahmoud Alilou M, Hashemi Nosratabad T, Sohrabi F. Effectiveness of combined intervention based acceptance and commitment therapy (ACT) with exposure techniques on patient's anxiety symptoms intensity and sensitivity dimensions in general anxiety disorder (GAD). J Clin Psychol. 2016;8:61-75. [Persian] [Link]
17. Zandifar A, Badrfam R. Iranian mental health during the COVID-19 epidemic. Asian J Psychiatry. 2020;51:101990. [Link] [DOI:10.1016/j.ajp.2020.101990]
18. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Inter Med. 2006;166(10):1092-7. [Link] [DOI:10.1001/archinte.166.10.1092]
19. Nunnally JC. Psychometric theory 3E. New York: Tata McGraw-Hill Education; 1994. [Link]
20. Delshad MH, Tavafian SS, Kazemnejad A. Designing and psychometric evaluation of stretching exercise influencing scale (SEIS). BMJ Open. 2019;9:e026565. [Link] [DOI:10.1136/bmjopen-2018-026565]
21. Delshad MH, Hidarnia A, Niknam S. Psychometric measure continuous variables preventive behaviors of hepatitis B virus infection in health care workers. J Mazandaran Univ Med Sci. 2014;23(109):71-82. [Link]
22. Raykov T, Marcoulides GA. A first course in structural equation modeling. London: Routledge; 2006. [Link]
23. Loehlin JC. Latent variable models: an introduction to factor, path, and structural equation analysis. Psychology Press; 2003. [Link]
24. Mohammadpour M, Ghorbani V, Moradi S, Khaki Z, Foroughi AA, Rezaei MR. Psychometric Properties of the Iranian Version of the Coronavirus Anxiety Scale. Iran J Psychiatry Clin Psychol. 2020;26(3):374-87. [Link] [DOI:10.32598/ijpcp.26.3482.1]
25. Hammarberg K, Tran T, Kirkman M, Fisher J. Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey. BMJ Open. 2020;10:e042696. [Link] [DOI:10.1136/bmjopen-2020-042696]
26. Mertens G, Gerritsen L, Duijndam S, Salemink E, Engelhard IM. Fear of the coronavirus (COVID-19): Predictors in an online study conducted in March 2020. J Anxiety Disord. 2020;74:102258. [Link] [DOI:10.1016/j.janxdis.2020.102258]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |